Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease.

The American journal of cardiology - 15 Sept 2009

Mager Aviv, Orvin Katia, Koren-Morag Nira, Lev Israel Eli, Assali Abid, Kornowski Ran, Shohat Mordechai, Battler Alexander, Hasdai David

Abstract excerpt

Elevated homocysteine levels are associated with increased risk for mortality in patients with coronary artery disease (CAD). However, the benefit of homocysteine-lowering therapy remains controversial. The aim of this study was to examine the impact of homocysteine-lowering therapy on the long-t...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Artery Disease
Share to Folic Acid
Share to Homocysteine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Mutation

Share to Survival Analysis

Share to Treatment Outcome

Share to Vitamin B Complex

Source

Identifiers

PMID: 19733705
DOI: 10.1016/j.amjcard.2009.05.011

Genes

CAD

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19733705-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease.PMID 19733705Read ↗

Influence of 677 C-->T polymorphism of methylenetetrahydrofolate reductase on medium-term prognosis after acute coronary syndromes.Semantic proximity Read ↗

Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD.Semantic proximity Read ↗

Homocysteine concentration in coronary artery disease: Influence of three common single nucleotide polymorphisms.Semantic proximity Read ↗

High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.Semantic proximity Read ↗

Family history, plasma homocysteine, and age at onset of symptoms of myocardial ischemia in patients with different methylenetetrahydrofolate reductase genotypes.Semantic proximity Read ↗

Plasma homocysteine and cardiovascular outcomes in postmenopausal women with coronary heart disease: a retrospective cohort studySemantic proximity Read ↗

C(1) metabolism and CVD outcomes in older adults.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase polymorphism determines the plasma homocysteine-lowering effect of large-dose folic acid supplementation in patients with cardiovascular disease.Semantic proximity Read ↗

Long-term Prognostic Value of Homocysteine in Patients with Acute Coronary Syndrome Complicated with Hypertension: A Multicenter Retrospective StudySemantic proximity Read ↗

The Association of Plasma Homocysteine Concentrations with a 10-Year Risk of All-Cause and Cardiovascular Mortality in a Community-Based Chinese Population.Semantic proximity Read ↗

Nutrigenetic impact of daily folate intake on plasma homocysteine and folate levels in patients with different methylenetetrahydrofolate reductase genotypes.Semantic proximity Read ↗

The methylenetetrahydrofolate reductase gene is associated with increased cardiovascular risk in Japan, but not in other populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.